BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Leopoulou M, Theofilis P, Kordalis A, Papageorgiou N, Sagris M, Oikonomou E, Tousoulis D. Diabetes mellitus and atrial fibrillation-from pathophysiology to treatment. World J Diabetes 2023; 14(5): 512-527 [PMID: 37273256 DOI: 10.4239/wjd.v14.i5.512]
URL: https://www.wjgnet.com/1948-9358/full/v14/i5/512.htm
Number Citing Articles
1
Kennedy Sparling, Mehrtash Hashemzadeh, Mohammad Reza Movahed. The Impact of Weight Categories on the Association Between Atrial Fibrillation/Flutter and Known Risk Factors: A Nationwide Inpatient Data AnalysisJournal of Clinical Medicine 2025; 14(7): 2187 doi: 10.3390/jcm14072187
2
F. O. Ushanova, M. Y. Izmailova, M. N. Nadybina. Cardiac arrhythmias in patients with type 2 diabetes mellitusFOCUS. Endocrinology 2024; 5(2): 12 doi: 10.62751/2713-0177-2024-5-2-12
3
Edward Zheng, Izabela Warchoł, Maja Mejza, Maria Możdżan, Monika Strzemińska, Anna Bajer, Paulina Madura, Juliusz Żak, Michał Plewka. Exploring Anti-Inflammatory Treatment as Upstream Therapy in the Management of Atrial FibrillationJournal of Clinical Medicine 2025; 14(3): 882 doi: 10.3390/jcm14030882
4
Jheng-Yan Wu, Kuan-Jui Tseng, Chia-Li Kao, Kuo-Chuan Hung, Tsung Yu, Yu-Min Lin. Clinical effectiveness of tirzepatide for patients with atrial fibrillation and type 2 diabetes: A retrospective cohort studyDiabetes Research and Clinical Practice 2025; 225: 112279 doi: 10.1016/j.diabres.2025.112279
5
DIAN OKTIANTI, ZAKKY CHOLISOH, SITI MAISHARAH SHEIKH GHADZI, HIDAYAH KARUNIAWATI. POTENTIAL OF DRUG INTERACTIONS IN HOSPITALIZED PATIENTS RECEIVING WARFARIN THERAPY FOR THE FIRST TIMEInternational Journal of Applied Pharmaceutics 2025; : 93 doi: 10.22159/ijap.2025.v17s2.14
6
Weiqiang Ruan, Xiaoqin Zhou, Jing Li, Huizhen Liu, Ting Wang, Guiying Zhang, Ke Lin. Type 2 diabetes mellitus and cardiovascular health: Evidence of causal relationships in a European ancestry populationESC Heart Failure 2024; 11(5): 3105 doi: 10.1002/ehf2.14877
7
Maryam Mohsin, Hafiz Zeyad, Hareem Khalid, Abubakar Gapizov, Ruqiya Bibi, Yashkumar Girdharlal Kamani , Ahmed Rashid, Muhammad Shams, Faizan Khalid, Syeda Khan, Muhammad Waqas, Anzal Ishfaq, Ayele H Kebede , Muhammad Subhan. The Synergistic Relationship Between Atrial Fibrillation and Diabetes Mellitus: Implications for Cardiovascular and Metabolic HealthCureus 2023;  doi: 10.7759/cureus.45881
8
Marios Sagris, Panayotis K. Vlachakis, Spyridon Simantiris, Panagiotis Theofilis, Maria Gerogianni, Paschalis Karakasis, Konstantinos Tsioufis, Dimitris Tousoulis. From a Cup of Tea to Cardiovascular Care: Vascular Mechanisms of ActionLife 2024; 14(9): 1168 doi: 10.3390/life14091168
9
Radostina Ilieva, Elena Kinova, Boris Slavchev, Petar Kalaydzhiev, Desislava Somleva, Assen Goudev. Clinical and echocardiographic characteristics of patients with atrial cardiomyopathy and their impact on prognosisFolia Medica 2024; 66(5): 608 doi: 10.3897/folmed.66.e135893
10
Hai Nguyen Ngoc Dang, Thang Viet Luong, Toan Thanh Tran. Evaluating left atrial function changes by speckle tracking echocardiography in type 2 diabetes patients in Central Vietnam: a cross-sectional comparative studyThe Egyptian Heart Journal 2024; 76(1) doi: 10.1186/s43044-024-00470-w
11
Katarina Tomović Pavlović, Marko Anderluh, Andrija Šmelcerović. Mechanisms of beneficial effects of DPP-4 inhibitors as a promising perspective for the prevention/treatment of the disruption of cardio-cerebrovascular homeostasisFrontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1642333
12
Rasmus Rørth, Margit Kriegbaum, Mia Klinten Grand, Peter Karl Jacobsen, Bent Struer Lind, Christen Lykkegaard Andersen, Frederik Persson. Risk of atrial fibrillation in individuals with dysglycemia and diabetesJournal of Diabetes and its Complications 2023; 37(9): 108579 doi: 10.1016/j.jdiacomp.2023.108579
13
Saed Bani Amer, Khaled Al-Sawalmeh, Yara Al-Slati, Lena Almemeh, Bayan Amoorah, Mohammad Melhem, Rowan Alzoubi, Abdulaziz Alanazi. Safety and Efficacy of Conventional Antithrombotics versus Direct Oral Anticoagulants in Diabetic Patients: A Jordanian-based cross-sectional studymedtigo Journal of Medicine 2024; 1(1): 1 doi: 10.63096/medtigo3062245
14
Mark S. Tyurypov, Polina O. Odnokol, Gennadiy G. Kutelev, Uliana A. Komarova. The new face of diabetes mellitus — rhythm and conduction disordersRussian Military Medical Academy Reports 2024; 43(2): 193 doi: 10.17816/rmmar627539
15
Paul Gabriel Ciubotaru, Nilima Rajpal Kundnani, Abhinav Sharma, Marioara Nicula Neagu, Vlad Sabin Ivan, Roxana Buzas, Nicolae Albulescu, Anca Raluca Dinu, Daniel Florin Lighezan. Hypertension and Diabetes as Determinants of Patient-Reported Quality of Life in Permanent Atrial FibrillationDiagnostics 2025; 15(21): 2674 doi: 10.3390/diagnostics15212674
16
Muhammad Ahad Nabil, Leanne Rychlik, Audrey Nicholson, Peter Cheung, Gregory D. Olsovsky, Jaime Molden, Ajay Tripuraneni, Shayan-Salehi Hajivandi, Javier E. Banchs. Dietary interventions in the management of atrial fibrillationFrontiers in Cardiovascular Medicine 2024; 11 doi: 10.3389/fcvm.2024.1418059
17
Usama Qamar, Farhan Naeem, Siddharth Agarwal. Trends and disparities in atrial fibrillation‐related mortality among adults with co‐morbid diabetes mellitus in the United StatesEuropean Journal of Clinical Investigation 2025; 55(5) doi: 10.1111/eci.14393
18
Roopeessh Vempati, Nanush Damarlapally, Poulami Roy, Maneeth Mylavarapu, Srivatsa Surya Vasudevan, Reshma Reguram, Tanisha Vora, Hritvik Jain, Raheel Ahmed, Geetha Krishnamoorthy. Metformin and Risk of New-Onset Atrial Fibrillation in Type 2 Diabetes: A Systematic Review and Meta-AnalysisDiagnostics 2025; 15(18): 2288 doi: 10.3390/diagnostics15182288
19
Carlos Escobar-Cervantes, Pablo Díez-Villanueva, Clara Bonanad Lozano, Antonio Pose Reino, Manuel Almendro-Delia, Lorenzo Facila, Alfonso Valle, Carmen Suárez. Vascular protection with rivaroxaban in the comprehensive management of atrial fibrillationExpert Review of Cardiovascular Therapy 2023; 21(11): 791 doi: 10.1080/14779072.2023.2276893
20
Xinwei Guo, Jingbo Li. Risk and Protective Factors of Recurrence after Catheter Ablation for Atrial FibrillationReviews in Cardiovascular Medicine 2024; 25(3) doi: 10.31083/j.rcm2503081
21
Dat Tran Cao, Chin-Yu Lin. Atrial Fibrillation - Current Management and PracticeCardiology and Cardiovascular Medicine 2024; 9 doi: 10.5772/intechopen.1006048
22
Carlos Escobar-Cervantes, Antonio Pose Reino, Pablo Díez-Villanueva, Lorenzo Facila, Román Freixa-Pamias, Alfonso Valle, Manuel Almendro-Delia, Clara Bonanad, David Vivas, Carmen Suarez. Should atrial fibrillation be considered a vascular disease? The need for a comprehensive vascular approachExpert Review of Cardiovascular Therapy 2023; 21(11): 779 doi: 10.1080/14779072.2023.2272652